Health policy is shaped at the intersection of medical innovation, regulation, economics and political priorities. New treatments and changes in service provision are assessed through decision-making processes in which clinical, financial and societal considerations must be weighed together.
Decisions are influenced by how value is understood and assessed across politics, public administration, health economics and clinical practice, from Parliament and ministries, through the relevant authorities, and into specialist healthcare services and local government.
Rud Pedersen supports a wide range of stakeholders that need to position themselves in this landscape through analysis, strategic counsel, communication and government engagement across areas including market access, reimbursement, regulatory processes and health policy.
Our health team combines experience from politics, the government’s apparatus, health administration, media, industry associations, companies and organisations. Together, this provides a deep insight into how decisions are made and which mechanisms shape the path towards them. We also support efforts to ensure that implementation and adoption reinforce the most important interactions in healthcare: those between patients and the professionals who treat them.
Through Rud Pedersen’s international network, we follow global and European health policy closely. This gives organisations access to up-to-date analysis and strategic assessments across national, European and global levels of decision-making.